Kazui et al. found that increased T-tau/Aβ42 as a measure of comorbid AD pathology was related to poorer shunt response in iNPH patients, whereas other studies reported no negative influence of AD pathology on outcome [20]. Here, MAPT is linked to Alzheimer disease.